A detailed history of Met Life Investment Management, LLC transactions in Insulet Corp stock. As of the latest transaction made, Met Life Investment Management, LLC holds 19,201 shares of PODD stock, worth $3.78 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
19,201
Holding current value
$3.78 Million
% of portfolio
0.02%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$163.6 - $209.11 $3.14 Million - $4.02 Million
19,201 New
19,201 $3.29 Million
Q4 2023

Feb 14, 2024

SELL
$127.77 - $221.42 $44,719 - $77,497
-350 Reduced 1.74%
19,794 $4.29 Million
Q3 2023

May 09, 2024

SELL
$154.67 - $290.89 $79,191 - $148,935
-512 Reduced 2.48%
20,144 $3.21 Million
Q3 2023

Apr 29, 2024

SELL
$154.67 - $290.89 $65,425 - $123,046
-423 Reduced 2.06%
20,144 $3.21 Million
Q3 2023

Nov 14, 2023

SELL
$154.67 - $290.89 $65,425 - $123,046
-423 Reduced 2.06%
20,144 $3.21 Million
Q2 2023

Apr 29, 2024

BUY
$272.48 - $330.23 $5.6 Million - $6.79 Million
20,567 New
20,567 $5.93 Million
Q2 2023

Aug 10, 2023

SELL
$272.48 - $330.23 $24,250 - $29,390
-89 Reduced 0.43%
20,567 $5.93 Million
Q1 2023

May 09, 2024

BUY
$276.36 - $326.03 $5.71 Million - $6.73 Million
20,656 New
20,656 $6.59 Billion
Q1 2023

May 15, 2023

BUY
$276.36 - $326.03 $4.56 Million - $5.38 Million
16,494 Added 396.3%
20,656 $6.59 Million
Q4 2022

May 10, 2024

SELL
$212.22 - $313.46 $23,344 - $34,480
-110 Reduced 2.57%
4,162 $1.23 Million
Q4 2022

Jun 14, 2023

SELL
$212.22 - $313.46 $3.5 Million - $5.17 Million
-16,494 Reduced 79.85%
4,162 $1.23 Million
Q4 2022

Mar 22, 2023

SELL
$212.22 - $313.46 $23,344 - $34,480
-110 Reduced 2.57%
4,162 $1.23 Million
Q4 2022

Feb 15, 2023

SELL
$212.22 - $313.46 $23,344 - $34,480
-110 Reduced 2.57%
4,162 $1.23 Million
Q3 2022

May 10, 2024

BUY
$224.6 - $281.45 $673 - $844
3 Added 0.07%
4,272 $979,000
Q3 2022

Jun 14, 2023

SELL
$224.6 - $281.45 $3.68 Million - $4.61 Million
-16,384 Reduced 79.32%
4,272 $979,000
Q3 2022

Mar 22, 2023

BUY
$224.6 - $281.45 $673 - $844
3 Added 0.07%
4,272 $979,000
Q3 2022

Nov 14, 2022

BUY
$224.6 - $281.45 $673 - $844
3 Added 0.07%
4,272 $980,000
Q2 2022

May 10, 2024

SELL
$186.4 - $279.02 $1,864 - $2,790
-10 Reduced 0.23%
4,269 $930,000
Q2 2022

Jun 20, 2023

SELL
$186.4 - $279.02 $3.05 Million - $4.57 Million
-16,387 Reduced 79.33%
4,269 $930,000
Q2 2022

Mar 22, 2023

SELL
$186.4 - $279.02 $1,864 - $2,790
-10 Reduced 0.23%
4,269 $930,000
Q2 2022

Aug 11, 2022

SELL
$186.4 - $279.02 $1,864 - $2,790
-10 Reduced 0.23%
4,269 $930,000
Q1 2022

May 10, 2024

BUY
$194.8 - $275.7 $833,549 - $1.18 Million
4,279 New
4,279 $1.14 Million
Q1 2022

Jun 20, 2023

SELL
$194.8 - $275.7 $3.19 Million - $4.52 Million
-16,377 Reduced 79.28%
4,279 $1.14 Million
Q1 2022

Mar 22, 2023

BUY
$194.8 - $275.7 $817,965 - $1.16 Million
4,199 Added 5248.75%
4,279 $1.14 Million
Q1 2022

May 12, 2022

BUY
$194.8 - $275.7 $833,549 - $1.18 Million
4,279 New
4,279 $1.14 Million
Q2 2019

Aug 14, 2019

SELL
$82.13 - $120.73 $6,570 - $9,658
-80 Closed
0 $0
Q1 2019

Jul 13, 2023

SELL
$72.44 - $101.87 $1.49 Million - $2.1 Million
-20,576 Reduced 99.61%
80 $7,000
Q4 2018

Jul 13, 2023

SELL
$73.27 - $105.19 $1.51 Million - $2.16 Million
-20,576 Reduced 99.61%
80 $6,000
Q3 2018

Jul 13, 2023

SELL
$81.43 - $108.13 $1.68 Million - $2.22 Million
-20,576 Reduced 99.61%
80 $8,000
Q3 2018

Mar 22, 2023

SELL
$81.43 - $108.13 $332,397 - $441,386
-4,082 Reduced 98.08%
80 $8,000
Q3 2018

Nov 14, 2018

BUY
$81.43 - $108.13 $6,514 - $8,650
80 New
80 $8,000
Q2 2018

Aug 15, 2018

SELL
$83.27 - $101.93 $2.18 Million - $2.66 Million
-26,143 Closed
0 $0
Q4 2017

Feb 15, 2018

BUY
$55.67 - $71.8 $1.46 Million - $1.88 Million
26,143
26,143 $1.8 Million

Others Institutions Holding PODD

About INSULET CORP


  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $13.7B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.